1Y Target$79.00Near-term target
5Y Target$161.27Compound horizon
10Y Target$419.65Long-dated conviction
FCF$438mTTM · 12/25CFCF $438m — modest; watch for margin expansion · TTM computed from 4 most-recent quarters (TTM · 12/25).
Rev+23.3%TTM YoYA-Revenue +23.3% — strong growth, well above S&P median (~7%)
D/E0.59B+D/E 0.59 — healthy leverage, well below danger zone
P/S5.0xBP/S 5.0x — in line with software/tech peers
PEG0.51A-PEG 0.51 — strong; Lynch's preferred zone
Why now
Specialty Chemicals · market cap $22.9b. 18% off the 52-week high of $98.00. Revenue growing +23%, comfortably above the S&P median. PEG 0.51 — paying under fair value for the growth rate. 18 sell-side analysts rate this a Buy with a mean 1-yr target of $79.00 (implying -1% upside).
Moat
Net margin 13% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent.
Risk
Speculative name — the thesis depends on a specific catalyst playing out (commercialization, regulatory milestone, market expansion). Position size accordingly; a 50% drawdown should not change the thesis.
Horizon
1-3 yr $79.00 (18-analyst consensus) — catalyst-driven; binary events dominate. 5 yr $161.27 — requires the platform / technology to reach commercial scale. 10 yr $419.65 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.